We endeavor to constantly innovate and improve the cardiovascular imaging software and clearly understand the ever-changing needs and requirements of physicians worldwide. We strive to serve them with clinical tools that provide for the best possible outcomes.
Through adherence to, and improvement of, our Quality Management System we continuously strive to be the leader in our industry, providing value added products for healthcare institutions worldwide, guided by our core values of trust, compliance and regard for the stakeholders.
To achieve this we will;
Circle Cardiovascular Imaging Inc. holds globally recognized ISO 13485:2016 certifications from prestigious British Standards Institution (BSI). This certification includes Standards Council of Canada (SCC) endorsement under Canadian Medical Device Conformity Assessment System (CMDCAS) scheme. In addition to ISO 13485:2016, the company quality system is established and maintained to comply with European Medical Device Directive 93/42/EEC, Australian Therapeutic Goods (Medical Devices) Regulations and US FDA Quality System Regulations, 21 CFR Part 820.
Circle Cardiovascular Imaging software development process is following the ANSI/AAMI/IEC 62304:2015 Medical device software — Software life cycle processes and associated standards and guidance documents. An intensive risk management process based on EN ISO 14971:2012 Medical device software risk management is in place to capture the potential risks and mitigate such risks as a part of the development process.
cvi42® has received market clearance from Health Canada, US FDA, Australian TGA, European Union, Brazilian ANVISA, China CFDA, Singapore HSA, Japan MHLW and South Korean KFDA*.
* MR only
Click the links provided below to download each document as specified below.
cvi42® is a Software Suite where ct42 and cmr42 functionality is integrated to a single general user interface (GUI).
If you require further information on Circle's Quality System or the regulatory approval status for Circle products, please contact the following:
Dr. Shirantha Samarappuli
Vice President — Regulatory Affairs and Quality Assurance.
Phone: +1 403 338 1870
Fax: +1 403 338 1895